

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of protein kinase C signaling (GO:0090037) | 9.69882735 |
| 2 | short-term memory (GO:0007614) | 9.61566427 |
| 3 | negative regulation of execution phase of apoptosis (GO:1900118) | 9.31873095 |
| 4 | protein localization to cilium (GO:0061512) | 8.16527783 |
| 5 | protein insertion into membrane (GO:0051205) | 7.97471525 |
| 6 | muscle filament sliding (GO:0030049) | 7.32529017 |
| 7 | actin-myosin filament sliding (GO:0033275) | 7.32529017 |
| 8 | GMP metabolic process (GO:0046037) | 7.19002901 |
| 9 | regulation of skeletal muscle contraction (GO:0014819) | 7.05419277 |
| 10 | sensory perception of chemical stimulus (GO:0007606) | 6.92409197 |
| 11 | melanin biosynthetic process (GO:0042438) | 6.51487050 |
| 12 | eyelid development in camera-type eye (GO:0061029) | 6.48754009 |
| 13 | regulation of protein kinase A signaling (GO:0010738) | 6.25000912 |
| 14 | metanephric tubule development (GO:0072170) | 6.16750089 |
| 15 | metanephric nephron tubule development (GO:0072234) | 6.16750089 |
| 16 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.13963800 |
| 17 | skeletal muscle contraction (GO:0003009) | 6.11672832 |
| 18 | actin-mediated cell contraction (GO:0070252) | 6.01946184 |
| 19 | melanin metabolic process (GO:0006582) | 5.94315140 |
| 20 | metanephric nephron epithelium development (GO:0072243) | 5.65801368 |
| 21 | regulation of chromatin binding (GO:0035561) | 5.64132460 |
| 22 | regulation of relaxation of muscle (GO:1901077) | 5.59057879 |
| 23 | secondary metabolite biosynthetic process (GO:0044550) | 5.46266604 |
| 24 | centriole replication (GO:0007099) | 5.32043148 |
| 25 | olfactory bulb development (GO:0021772) | 5.30726800 |
| 26 | metanephric epithelium development (GO:0072207) | 5.27386202 |
| 27 | UV protection (GO:0009650) | 5.27385946 |
| 28 | protein heterotetramerization (GO:0051290) | 5.26392251 |
| 29 | mRNA modification (GO:0016556) | 5.21047779 |
| 30 | regulation of protein kinase C signaling (GO:0090036) | 5.19666005 |
| 31 | collecting duct development (GO:0072044) | 5.16139737 |
| 32 | regulation of execution phase of apoptosis (GO:1900117) | 5.11791400 |
| 33 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.92426078 |
| 34 | central nervous system myelination (GO:0022010) | 4.72394246 |
| 35 | axon ensheathment in central nervous system (GO:0032291) | 4.72394246 |
| 36 | postsynaptic membrane organization (GO:0001941) | 4.70872256 |
| 37 | maternal placenta development (GO:0001893) | 4.61056060 |
| 38 | presynaptic membrane assembly (GO:0097105) | 4.57085620 |
| 39 | axoneme assembly (GO:0035082) | 4.40766698 |
| 40 | response to muscle activity (GO:0014850) | 4.40108232 |
| 41 | retina layer formation (GO:0010842) | 4.37058252 |
| 42 | striated muscle contraction (GO:0006941) | 4.35420423 |
| 43 | myofibril assembly (GO:0030239) | 4.33750488 |
| 44 | facial nerve structural organization (GO:0021612) | 4.32307184 |
| 45 | regulation of glucokinase activity (GO:0033131) | 4.30686028 |
| 46 | regulation of hexokinase activity (GO:1903299) | 4.30686028 |
| 47 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.25531087 |
| 48 | axonemal dynein complex assembly (GO:0070286) | 4.15764304 |
| 49 | interkinetic nuclear migration (GO:0022027) | 4.02449241 |
| 50 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.00929337 |
| 51 | creatine metabolic process (GO:0006600) | 3.99282199 |
| 52 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.93003817 |
| 53 | negative regulation of astrocyte differentiation (GO:0048712) | 3.92910481 |
| 54 | actin filament-based movement (GO:0030048) | 3.92290430 |
| 55 | presynaptic membrane organization (GO:0097090) | 3.87174622 |
| 56 | respiratory chain complex IV assembly (GO:0008535) | 3.84400622 |
| 57 | nephron epithelium development (GO:0072009) | 3.84078413 |
| 58 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.83811567 |
| 59 | centriole assembly (GO:0098534) | 3.82664485 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 3.81195008 |
| 61 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.77599160 |
| 62 | skeletal muscle fiber development (GO:0048741) | 3.77097411 |
| 63 | nephron tubule development (GO:0072080) | 3.76372194 |
| 64 | regulation of cilium movement (GO:0003352) | 3.75341779 |
| 65 | cytochrome complex assembly (GO:0017004) | 3.74275837 |
| 66 | regulation of cell communication by electrical coupling (GO:0010649) | 3.72883742 |
| 67 | inositol phosphate catabolic process (GO:0071545) | 3.69061905 |
| 68 | sarcomere organization (GO:0045214) | 3.68460891 |
| 69 | protein complex biogenesis (GO:0070271) | 3.65067167 |
| 70 | myotube cell development (GO:0014904) | 3.63765573 |
| 71 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 3.63130126 |
| 72 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.58434591 |
| 73 | inositol phosphate dephosphorylation (GO:0046855) | 3.58434591 |
| 74 | neuron cell-cell adhesion (GO:0007158) | 3.55936927 |
| 75 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.55212854 |
| 76 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.54190980 |
| 77 | regulation of development, heterochronic (GO:0040034) | 3.52658927 |
| 78 | ubiquinone biosynthetic process (GO:0006744) | 3.50870744 |
| 79 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.50179456 |
| 80 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.49100931 |
| 81 | muscle contraction (GO:0006936) | 3.48911817 |
| 82 | auditory receptor cell differentiation (GO:0042491) | 3.46566073 |
| 83 | renal tubule development (GO:0061326) | 3.43385474 |
| 84 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.41022432 |
| 85 | response to inactivity (GO:0014854) | 3.36843269 |
| 86 | ovulation cycle (GO:0042698) | 3.36076753 |
| 87 | protein polyglutamylation (GO:0018095) | 3.32569433 |
| 88 | respiratory tube development (GO:0030323) | 3.32340369 |
| 89 | ketone body metabolic process (GO:1902224) | 3.32195653 |
| 90 | respiratory electron transport chain (GO:0022904) | 3.29612441 |
| 91 | electron transport chain (GO:0022900) | 3.28981358 |
| 92 | regulation of female gonad development (GO:2000194) | 3.27159279 |
| 93 | cranial nerve structural organization (GO:0021604) | 3.26294480 |
| 94 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.25324352 |
| 95 | * glycogen catabolic process (GO:0005980) | 3.24389094 |
| 96 | cilium movement (GO:0003341) | 3.23540231 |
| 97 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.23537118 |
| 98 | AMP metabolic process (GO:0046033) | 3.23161831 |
| 99 | DNA methylation involved in gamete generation (GO:0043046) | 3.18997470 |
| 100 | neuronal action potential propagation (GO:0019227) | 3.17245159 |
| 101 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.16994577 |
| 102 | intraciliary transport (GO:0042073) | 3.16125615 |
| 103 | mannose metabolic process (GO:0006013) | 3.14059546 |
| 104 | regulation of timing of cell differentiation (GO:0048505) | 3.13612450 |
| 105 | muscle system process (GO:0003012) | 3.12897084 |
| 106 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.11466995 |
| 107 | microtubule severing (GO:0051013) | 3.10273855 |
| 108 | positive regulation of calcium ion import (GO:0090280) | 3.07565879 |
| 109 | positive regulation of glycolytic process (GO:0045821) | 3.05275729 |
| 110 | * glucan catabolic process (GO:0009251) | 3.04806952 |
| 111 | muscle fiber development (GO:0048747) | 3.03820596 |
| 112 | ubiquinone metabolic process (GO:0006743) | 3.03811620 |
| 113 | cilium morphogenesis (GO:0060271) | 3.02593456 |
| 114 | plasma membrane repair (GO:0001778) | 3.01717043 |
| 115 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.00087421 |
| 116 | regulation of membrane repolarization (GO:0060306) | 2.99712121 |
| 117 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.99252296 |
| 118 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.99252296 |
| 119 | cellular response to virus (GO:0098586) | 2.98472849 |
| 120 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.98157247 |
| 121 | positive regulation of glycogen metabolic process (GO:0070875) | 2.98075701 |
| 122 | photoreceptor cell maintenance (GO:0045494) | 2.97176281 |
| 123 | zinc ion transmembrane transport (GO:0071577) | 2.96670972 |
| 124 | adenosine metabolic process (GO:0046085) | 2.94389927 |
| 125 | polyol catabolic process (GO:0046174) | 2.94339745 |
| 126 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.92812623 |
| 127 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.92763391 |
| 128 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.92763391 |
| 129 | NADH dehydrogenase complex assembly (GO:0010257) | 2.92763391 |
| 130 | response to folic acid (GO:0051593) | 2.91201475 |
| 131 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.89887217 |
| 132 | nonmotile primary cilium assembly (GO:0035058) | 2.88961443 |
| 133 | actomyosin structure organization (GO:0031032) | 2.88081564 |
| 134 | xenobiotic catabolic process (GO:0042178) | 2.87214534 |
| 135 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.85273498 |
| 136 | regulation of actin filament-based movement (GO:1903115) | 2.84406630 |
| 137 | cardiac muscle contraction (GO:0060048) | 2.81729929 |
| 138 | skeletal muscle adaptation (GO:0043501) | 2.81420543 |
| 139 | centrosome duplication (GO:0051298) | 2.81095378 |
| 140 | DNA deamination (GO:0045006) | 2.80099368 |
| 141 | skeletal muscle tissue development (GO:0007519) | 2.79793045 |
| 142 | succinate metabolic process (GO:0006105) | 2.78040772 |
| 143 | * glucan biosynthetic process (GO:0009250) | 2.77886330 |
| 144 | * glycogen biosynthetic process (GO:0005978) | 2.77886330 |
| 145 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.77727484 |
| 146 | dopamine transport (GO:0015872) | 2.77341844 |
| 147 | branched-chain amino acid catabolic process (GO:0009083) | 2.76752752 |
| 148 | quinone biosynthetic process (GO:1901663) | 2.76065735 |
| 149 | epithelial cell morphogenesis (GO:0003382) | 2.74681502 |
| 150 | fatty acid transmembrane transport (GO:1902001) | 2.74485959 |
| 151 | renal system development (GO:0072001) | 2.73095044 |
| 152 | cardiac myofibril assembly (GO:0055003) | 2.72605015 |
| 153 | regulation of striated muscle contraction (GO:0006942) | 2.72564155 |
| 154 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.67181284 |
| 155 | positive regulation of cation channel activity (GO:2001259) | 2.65425726 |
| 156 | establishment of viral latency (GO:0019043) | 2.64704086 |
| 157 | regulation of keratinocyte proliferation (GO:0010837) | 2.64446797 |
| 158 | retina development in camera-type eye (GO:0060041) | 2.64261667 |
| 159 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.63811831 |
| 160 | omega-hydroxylase P450 pathway (GO:0097267) | 2.63418049 |
| 161 | carnitine shuttle (GO:0006853) | 2.63281632 |
| 162 | ganglion development (GO:0061548) | 2.63191170 |
| 163 | regulation of oxidative phosphorylation (GO:0002082) | 2.62758707 |
| 164 | alanine transport (GO:0032328) | 2.62118781 |
| 165 | magnesium ion transport (GO:0015693) | 2.61792877 |
| 166 | nitric oxide mediated signal transduction (GO:0007263) | 2.61314438 |
| 167 | epithelial cilium movement (GO:0003351) | 2.60716005 |
| 168 | cell proliferation in forebrain (GO:0021846) | 2.59935076 |
| 169 | ADP metabolic process (GO:0046031) | 2.59659155 |
| 170 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.59617725 |
| 171 | innate immune response in mucosa (GO:0002227) | 2.59326555 |
| 172 | Leydig cell differentiation (GO:0033327) | 2.59166378 |
| 173 | negative regulation of complement activation (GO:0045916) | 2.57988615 |
| 174 | valine metabolic process (GO:0006573) | 2.56950199 |
| 175 | lipid particle organization (GO:0034389) | 2.56949688 |
| 176 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 2.56939327 |
| 177 | behavioral response to nicotine (GO:0035095) | 2.55663612 |
| 178 | spermatid nucleus differentiation (GO:0007289) | 2.55589212 |
| 179 | regulation of energy homeostasis (GO:2000505) | 2.54988752 |
| 180 | cytidine deamination (GO:0009972) | 2.54091766 |
| 181 | cytidine metabolic process (GO:0046087) | 2.54091766 |
| 182 | cytidine catabolic process (GO:0006216) | 2.54091766 |
| 183 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.53255358 |
| 184 | * cellular polysaccharide catabolic process (GO:0044247) | 2.52433164 |
| 185 | regulation of sequestering of triglyceride (GO:0010889) | 2.52418760 |
| 186 | mucosal immune response (GO:0002385) | 2.51710321 |
| 187 | forebrain neuron development (GO:0021884) | 2.51456198 |
| 188 | chemical homeostasis within a tissue (GO:0048875) | 2.51371434 |
| 189 | adipose tissue development (GO:0060612) | 2.51332085 |
| 190 | insulin secretion (GO:0030073) | 2.50844172 |
| 191 | purine nucleotide salvage (GO:0032261) | 2.50280418 |
| 192 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.50059304 |
| 193 | neurogenesis (GO:0022008) | 2.46818844 |
| 194 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.46761784 |
| 195 | DNA methylation (GO:0006306) | 2.45584591 |
| 196 | DNA alkylation (GO:0006305) | 2.45584591 |
| 197 | sensory perception of smell (GO:0007608) | 11.8643206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 8.62566354 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.95266612 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.89736538 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.21620609 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 3.17885851 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.81399574 |
| 7 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.64994367 |
| 8 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.48619183 |
| 9 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.32743329 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.32397346 |
| 11 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.31721090 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.28099567 |
| 13 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.23209705 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.23116379 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.20401812 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.20401812 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.20349574 |
| 18 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.14334768 |
| 19 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.13829425 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.13619841 |
| 21 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.11708699 |
| 22 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.03991563 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.00522510 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.93547877 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.89630461 |
| 26 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.89571562 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.85046840 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.82563205 |
| 29 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.80198141 |
| 30 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.75297681 |
| 31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.74233874 |
| 32 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.69067869 |
| 33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.67214333 |
| 34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.67111035 |
| 35 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.62309926 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61326865 |
| 37 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.59210576 |
| 38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.59106057 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.57397550 |
| 40 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.56723159 |
| 41 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.56459323 |
| 42 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.56078822 |
| 43 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.55314008 |
| 44 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.53003133 |
| 45 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.52758629 |
| 46 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.52758629 |
| 47 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.52498382 |
| 48 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.51794843 |
| 49 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48694941 |
| 50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.48649754 |
| 51 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.48421207 |
| 52 | FUS_26573619_Chip-Seq_HEK293_Human | 1.46229520 |
| 53 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.44256376 |
| 54 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.40297378 |
| 55 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40048144 |
| 56 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.39894115 |
| 57 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39894115 |
| 58 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.39765013 |
| 59 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.39368433 |
| 60 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.38331664 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37325431 |
| 62 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.34138456 |
| 63 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.33995703 |
| 64 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.33312805 |
| 65 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31328428 |
| 66 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29834872 |
| 67 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29098009 |
| 68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.28981306 |
| 69 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.27450298 |
| 70 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.27450298 |
| 71 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.26863759 |
| 72 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.25920231 |
| 73 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.25717450 |
| 74 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.25717450 |
| 75 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.25292039 |
| 76 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24875356 |
| 77 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.24834759 |
| 78 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24387991 |
| 79 | AR_20517297_ChIP-Seq_VCAP_Human | 1.23277105 |
| 80 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.22681346 |
| 81 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22614303 |
| 82 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22320138 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.22012099 |
| 84 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21802095 |
| 85 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.20838371 |
| 86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20671486 |
| 87 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.20042104 |
| 88 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18951322 |
| 89 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18580670 |
| 90 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.18163603 |
| 91 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17954442 |
| 92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17546648 |
| 93 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17295582 |
| 94 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17153982 |
| 95 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.16325829 |
| 96 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.16300705 |
| 97 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.15494207 |
| 98 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15142006 |
| 99 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13442764 |
| 100 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12856052 |
| 101 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11939211 |
| 102 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11386542 |
| 103 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.11360558 |
| 104 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11121086 |
| 105 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10334551 |
| 106 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.09271843 |
| 107 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.08935448 |
| 108 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08581281 |
| 109 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.08270977 |
| 110 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.08118585 |
| 111 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.07204184 |
| 112 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07135213 |
| 113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06932039 |
| 114 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.06663468 |
| 115 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.06593365 |
| 116 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06228433 |
| 117 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.05421124 |
| 118 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04397976 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04098080 |
| 120 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.03009128 |
| 121 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02746088 |
| 122 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.02735966 |
| 123 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02379690 |
| 124 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.02149132 |
| 125 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.01981705 |
| 126 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01688200 |
| 127 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.01385109 |
| 128 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.01278031 |
| 129 | * NCOR_22424771_ChIP-Seq_293T_Human | 1.00871486 |
| 130 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.00576882 |
| 131 | * MYC_19829295_ChIP-Seq_ESCs_Human | 1.00359402 |
| 132 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.00241839 |
| 133 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00080469 |
| 134 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99831490 |
| 135 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99186512 |
| 136 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98933878 |
| 137 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.98781723 |
| 138 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98727538 |
| 139 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.98596153 |
| 140 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.98001009 |
| 141 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97849648 |
| 142 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.97581589 |
| 143 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.97266936 |
| 144 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.96682552 |
| 145 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96263788 |
| 146 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.95583353 |
| 147 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95391934 |
| 148 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.93085436 |
| 149 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.92976247 |
| 150 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.92849207 |
| 151 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92630100 |
| 152 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.92254872 |
| 153 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92216855 |
| 154 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92054089 |
| 155 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.91976881 |
| 156 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91808926 |
| 157 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.90565435 |
| 158 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.89921870 |
| 159 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89373736 |
| 160 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.88900302 |
| 161 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.88828806 |
| 162 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.88647027 |
| 163 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.88143304 |
| 164 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.86735019 |
| 165 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86595007 |
| 166 | GATA1_22025678_ChIP-Seq_K562_Human | 0.85981900 |
| 167 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.85420959 |
| 168 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84852372 |
| 169 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.84604281 |
| 170 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.84580378 |
| 171 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.83803603 |
| 172 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.83112914 |
| 173 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.83047885 |
| 174 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.82322576 |
| 175 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.81401761 |
| 176 | NFYB_21822215_ChIP-Seq_K562_Human | 0.81144174 |
| 177 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.80790508 |
| 178 | MAF_26560356_Chip-Seq_TH2_Human | 0.80305752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 9.46471371 |
| 2 | MP0001984_abnormal_olfaction | 6.13495858 |
| 3 | MP0005409_darkened_coat_color | 6.02112702 |
| 4 | MP0003646_muscle_fatigue | 5.75408258 |
| 5 | MP0001188_hyperpigmentation | 5.71056178 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 5.38329098 |
| 7 | MP0004381_abnormal_hair_follicle | 5.29569199 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 5.00227638 |
| 9 | MP0000749_muscle_degeneration | 4.11852911 |
| 10 | MP0005174_abnormal_tail_pigmentation | 3.60788738 |
| 11 | MP0000751_myopathy | 3.41624343 |
| 12 | MP0004036_abnormal_muscle_relaxation | 3.10003571 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.84339400 |
| 14 | MP0000013_abnormal_adipose_tissue | 2.68301378 |
| 15 | MP0002106_abnormal_muscle_physiology | 2.64257120 |
| 16 | MP0006036_abnormal_mitochondrial_physio | 2.58063045 |
| 17 | MP0000015_abnormal_ear_pigmentation | 2.35706738 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.33903050 |
| 19 | MP0004742_abnormal_vestibular_system | 2.29613821 |
| 20 | MP0005369_muscle_phenotype | 2.23365731 |
| 21 | MP0005620_abnormal_muscle_contractility | 2.21861972 |
| 22 | MP0004215_abnormal_myocardial_fiber | 2.17117909 |
| 23 | MP0000747_muscle_weakness | 2.15464033 |
| 24 | MP0002876_abnormal_thyroid_physiology | 2.14206964 |
| 25 | MP0008789_abnormal_olfactory_epithelium | 2.11953249 |
| 26 | MP0003195_calcinosis | 2.09316434 |
| 27 | MP0004084_abnormal_cardiac_muscle | 2.08542628 |
| 28 | MP0002269_muscular_atrophy | 2.06887185 |
| 29 | MP0009379_abnormal_foot_pigmentation | 2.04741582 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.99917091 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 1.99657815 |
| 32 | MP0005330_cardiomyopathy | 1.97444138 |
| 33 | MP0004130_abnormal_muscle_cell | 1.96774026 |
| 34 | MP0005379_endocrine/exocrine_gland_phen | 1.94110103 |
| 35 | MP0004087_abnormal_muscle_fiber | 1.92318392 |
| 36 | MP0000759_abnormal_skeletal_muscle | 1.90861646 |
| 37 | MP0002163_abnormal_gland_morphology | 1.80160920 |
| 38 | MP0002972_abnormal_cardiac_muscle | 1.59595516 |
| 39 | MP0000566_synostosis | 1.59594502 |
| 40 | MP0002638_abnormal_pupillary_reflex | 1.56993285 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.56706525 |
| 42 | MP0000750_abnormal_muscle_regeneration | 1.56017275 |
| 43 | MP0004043_abnormal_pH_regulation | 1.55200939 |
| 44 | MP0002102_abnormal_ear_morphology | 1.52085391 |
| 45 | MP0001853_heart_inflammation | 1.49790068 |
| 46 | MP0003252_abnormal_bile_duct | 1.47489985 |
| 47 | MP0008775_abnormal_heart_ventricle | 1.46311310 |
| 48 | MP0001485_abnormal_pinna_reflex | 1.44765629 |
| 49 | MP0006072_abnormal_retinal_apoptosis | 1.44414685 |
| 50 | MP0005423_abnormal_somatic_nervous | 1.44029317 |
| 51 | MP0005394_taste/olfaction_phenotype | 1.43938651 |
| 52 | MP0005499_abnormal_olfactory_system | 1.43938651 |
| 53 | MP0002693_abnormal_pancreas_physiology | 1.43042745 |
| 54 | MP0004270_analgesia | 1.39388109 |
| 55 | MP0005332_abnormal_amino_acid | 1.37655935 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.37436591 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.36322662 |
| 58 | MP0002282_abnormal_trachea_morphology | 1.34376884 |
| 59 | MP0005083_abnormal_biliary_tract | 1.33283812 |
| 60 | MP0005266_abnormal_metabolism | 1.33135301 |
| 61 | MP0001968_abnormal_touch/_nociception | 1.26748883 |
| 62 | MP0003941_abnormal_skin_development | 1.25848270 |
| 63 | MP0004147_increased_porphyrin_level | 1.25200330 |
| 64 | MP0001944_abnormal_pancreas_morphology | 1.24480279 |
| 65 | MP0009046_muscle_twitch | 1.24392009 |
| 66 | MP0001299_abnormal_eye_distance/ | 1.23033215 |
| 67 | MP0002909_abnormal_adrenal_gland | 1.22689090 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 1.19733963 |
| 69 | MP0003137_abnormal_impulse_conducting | 1.18628888 |
| 70 | MP0000049_abnormal_middle_ear | 1.18087127 |
| 71 | MP0002160_abnormal_reproductive_system | 1.17955518 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.16179149 |
| 73 | MP0002177_abnormal_outer_ear | 1.15548931 |
| 74 | MP0003315_abnormal_perineum_morphology | 1.15183798 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 1.13424363 |
| 76 | MP0002108_abnormal_muscle_morphology | 1.13120551 |
| 77 | MP0005257_abnormal_intraocular_pressure | 1.12540191 |
| 78 | MP0002752_abnormal_somatic_nervous | 1.10958870 |
| 79 | MP0003937_abnormal_limbs/digits/tail_de | 1.10601739 |
| 80 | MP0005451_abnormal_body_composition | 1.10110632 |
| 81 | MP0001501_abnormal_sleep_pattern | 1.08824624 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 1.08110231 |
| 83 | MP0003303_peritoneal_inflammation | 1.07502540 |
| 84 | MP0008872_abnormal_physiological_respon | 1.06699801 |
| 85 | MP0002184_abnormal_innervation | 1.05475529 |
| 86 | MP0004233_abnormal_muscle_weight | 1.05343766 |
| 87 | MP0004133_heterotaxia | 1.04599047 |
| 88 | MP0002095_abnormal_skin_pigmentation | 1.04287737 |
| 89 | MP0004142_abnormal_muscle_tone | 1.04103554 |
| 90 | MP0009250_abnormal_appendicular_skeleto | 1.03939074 |
| 91 | MP0003693_abnormal_embryo_hatching | 1.03101177 |
| 92 | MP0005253_abnormal_eye_physiology | 1.00934043 |
| 93 | MP0004085_abnormal_heartbeat | 1.00304771 |
| 94 | MP0002928_abnormal_bile_duct | 0.99145792 |
| 95 | MP0002249_abnormal_larynx_morphology | 0.98752980 |
| 96 | MP0004510_myositis | 0.98258748 |
| 97 | MP0006292_abnormal_olfactory_placode | 0.98044862 |
| 98 | MP0000003_abnormal_adipose_tissue | 0.97873862 |
| 99 | MP0001486_abnormal_startle_reflex | 0.97791199 |
| 100 | MP0001340_abnormal_eyelid_morphology | 0.95141842 |
| 101 | MP0003718_maternal_effect | 0.94203681 |
| 102 | MP0002233_abnormal_nose_morphology | 0.92996390 |
| 103 | MP0002653_abnormal_ependyma_morphology | 0.91959494 |
| 104 | MP0005595_abnormal_vascular_smooth | 0.91565030 |
| 105 | MP0001286_abnormal_eye_development | 0.91334403 |
| 106 | MP0004885_abnormal_endolymph | 0.90756970 |
| 107 | MP0003787_abnormal_imprinting | 0.90750842 |
| 108 | MP0001756_abnormal_urination | 0.90554501 |
| 109 | MP0010329_abnormal_lipoprotein_level | 0.90279952 |
| 110 | MP0005535_abnormal_body_temperature | 0.90175221 |
| 111 | MP0000858_altered_metastatic_potential | 0.89695146 |
| 112 | MP0003724_increased_susceptibility_to | 0.88166278 |
| 113 | MP0005385_cardiovascular_system_phenoty | 0.87106597 |
| 114 | MP0001544_abnormal_cardiovascular_syste | 0.87106597 |
| 115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86723676 |
| 116 | MP0000230_abnormal_systemic_arterial | 0.85510149 |
| 117 | MP0009764_decreased_sensitivity_to | 0.84030169 |
| 118 | MP0004484_altered_response_of | 0.83658282 |
| 119 | MP0001905_abnormal_dopamine_level | 0.83221475 |
| 120 | MP0005636_abnormal_mineral_homeostasis | 0.82793710 |
| 121 | MP0009745_abnormal_behavioral_response | 0.82668953 |
| 122 | MP0003283_abnormal_digestive_organ | 0.82452161 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.81257692 |
| 124 | MP0003938_abnormal_ear_development | 0.80583295 |
| 125 | MP0005165_increased_susceptibility_to | 0.79702181 |
| 126 | MP0001293_anophthalmia | 0.79188421 |
| 127 | MP0001542_abnormal_bone_strength | 0.78395963 |
| 128 | MP0009384_cardiac_valve_regurgitation | 0.76496150 |
| 129 | MP0002971_abnormal_brown_adipose | 0.76465139 |
| 130 | MP0005085_abnormal_gallbladder_physiolo | 0.76404122 |
| 131 | MP0005551_abnormal_eye_electrophysiolog | 0.75555784 |
| 132 | MP0003045_fibrosis | 0.74690695 |
| 133 | MP0002254_reproductive_system_inflammat | 0.74505887 |
| 134 | MP0010234_abnormal_vibrissa_follicle | 0.73433916 |
| 135 | MP0003879_abnormal_hair_cell | 0.73106475 |
| 136 | MP0002092_abnormal_eye_morphology | 0.72486497 |
| 137 | MP0003011_delayed_dark_adaptation | 0.69450503 |
| 138 | MP0003453_abnormal_keratinocyte_physiol | 0.69182068 |
| 139 | MP0004134_abnormal_chest_morphology | 0.67302678 |
| 140 | MP0002882_abnormal_neuron_morphology | 0.66918984 |
| 141 | MP0001661_extended_life_span | 0.65986981 |
| 142 | MP0009333_abnormal_splenocyte_physiolog | 0.65838745 |
| 143 | MP0002067_abnormal_sensory_capabilities | 0.65824443 |
| 144 | MP0003880_abnormal_central_pattern | 0.65787169 |
| 145 | MP0004883_abnormal_blood_vessel | 0.65593805 |
| 146 | MP0005220_abnormal_exocrine_pancreas | 0.65567302 |
| 147 | MP0010386_abnormal_urinary_bladder | 0.64500106 |
| 148 | MP0002139_abnormal_hepatobiliary_system | 0.64216900 |
| 149 | MP0002152_abnormal_brain_morphology | 0.63449972 |
| 150 | MP0008875_abnormal_xenobiotic_pharmacok | 0.63008517 |
| 151 | MP0001970_abnormal_pain_threshold | 0.61911993 |
| 152 | MP0005367_renal/urinary_system_phenotyp | 0.61322402 |
| 153 | MP0000516_abnormal_urinary_system | 0.61322402 |
| 154 | MP0001764_abnormal_homeostasis | 0.61210058 |
| 155 | MP0006035_abnormal_mitochondrial_morpho | 0.60664266 |
| 156 | MP0005365_abnormal_bile_salt | 0.60555387 |
| 157 | MP0000427_abnormal_hair_cycle | 0.60379168 |
| 158 | MP0005448_abnormal_energy_balance | 0.59441832 |
| 159 | MP0005075_abnormal_melanosome_morpholog | 0.58542343 |
| 160 | MP0005452_abnormal_adipose_tissue | 0.58536485 |
| 161 | MP0000767_abnormal_smooth_muscle | 0.58481705 |
| 162 | MP0002557_abnormal_social/conspecific_i | 0.58116914 |
| 163 | MP0002064_seizures | 0.58008579 |
| 164 | MP0005195_abnormal_posterior_eye | 0.57852479 |
| 165 | MP0005319_abnormal_enzyme/_coenzyme | 0.57551780 |
| 166 | MP0002751_abnormal_autonomic_nervous | 0.56706913 |
| 167 | MP0000467_abnormal_esophagus_morphology | 0.56063123 |
| 168 | MP0009765_abnormal_xenobiotic_induced | 0.55977125 |
| 169 | MP0005164_abnormal_response_to | 0.55899951 |
| 170 | MP0002734_abnormal_mechanical_nocicepti | 0.55829339 |
| 171 | MP0005360_urolithiasis | 0.55390471 |
| 172 | MP0000778_abnormal_nervous_system | 0.54568241 |
| 173 | MP0000372_irregular_coat_pigmentation | 0.54001780 |
| 174 | MP0000432_abnormal_head_morphology | 0.52356522 |
| 175 | MP0003861_abnormal_nervous_system | 0.52071013 |
| 176 | MP0002272_abnormal_nervous_system | 0.51078216 |
| 177 | MP0003935_abnormal_craniofacial_develop | 0.49729067 |
| 178 | MP0000579_abnormal_nail_morphology | 0.49221114 |
| 179 | MP0008877_abnormal_DNA_methylation | 0.47614290 |
| 180 | MP0000428_abnormal_craniofacial_morphol | 0.47601818 |
| 181 | MP0005197_abnormal_uvea_morphology | 0.46317852 |
| 182 | MP0002127_abnormal_cardiovascular_syste | 0.45935892 |
| 183 | MP0005647_abnormal_sex_gland | 0.45838842 |
| 184 | MP0002098_abnormal_vibrissa_morphology | 0.45057540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sex reversal (HP:0012245) | 8.38728456 |
| 2 | Abnormal sex determination (HP:0012244) | 8.38728456 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 8.20103531 |
| 4 | Nemaline bodies (HP:0003798) | 8.09746813 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.83654091 |
| 6 | Abnormality of secondary sexual hair (HP:0009888) | 6.66062457 |
| 7 | Abnormality of the axillary hair (HP:0100134) | 6.66062457 |
| 8 | Obstructive sleep apnea (HP:0002870) | 6.28649906 |
| 9 | Abnormal biliary tract physiology (HP:0012439) | 6.08193624 |
| 10 | Bile duct proliferation (HP:0001408) | 6.08193624 |
| 11 | Exercise-induced myalgia (HP:0003738) | 5.88913966 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 5.71057198 |
| 13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.60635308 |
| 14 | Type 1 muscle fiber predominance (HP:0003803) | 5.47966073 |
| 15 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.31992767 |
| 16 | Calf muscle hypertrophy (HP:0008981) | 5.15108337 |
| 17 | Distal arthrogryposis (HP:0005684) | 4.71446164 |
| 18 | Rhinitis (HP:0012384) | 4.55045657 |
| 19 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.44686760 |
| 20 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.44686760 |
| 21 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.27513584 |
| 22 | Abnormal ciliary motility (HP:0012262) | 4.18428606 |
| 23 | EMG: myopathic abnormalities (HP:0003458) | 4.16775523 |
| 24 | Split foot (HP:0001839) | 4.10909585 |
| 25 | Myopathic facies (HP:0002058) | 3.99375985 |
| 26 | Myoglobinuria (HP:0002913) | 3.97860424 |
| 27 | Chronic bronchitis (HP:0004469) | 3.92419260 |
| 28 | Rhabdomyolysis (HP:0003201) | 3.84263859 |
| 29 | Round ear (HP:0100830) | 3.70966058 |
| 30 | Alacrima (HP:0000522) | 3.65541088 |
| 31 | Abnormality of the calf musculature (HP:0001430) | 3.65527390 |
| 32 | Supernumerary spleens (HP:0009799) | 3.58585835 |
| 33 | Rimmed vacuoles (HP:0003805) | 3.41798189 |
| 34 | Hyporeflexia of lower limbs (HP:0002600) | 3.41204173 |
| 35 | Sleep apnea (HP:0010535) | 3.32567636 |
| 36 | Gonadal dysgenesis (HP:0000133) | 3.26055007 |
| 37 | Decreased lacrimation (HP:0000633) | 3.14888364 |
| 38 | Ulnar deviation of the wrist (HP:0003049) | 3.14167714 |
| 39 | Septo-optic dysplasia (HP:0100842) | 3.13383660 |
| 40 | Neck muscle weakness (HP:0000467) | 3.08301651 |
| 41 | Progressive macrocephaly (HP:0004481) | 3.04695852 |
| 42 | Muscle fiber splitting (HP:0003555) | 3.04064927 |
| 43 | Attenuation of retinal blood vessels (HP:0007843) | 3.04039034 |
| 44 | Acute necrotizing encephalopathy (HP:0006965) | 3.01555100 |
| 45 | Joint hemorrhage (HP:0005261) | 2.96000122 |
| 46 | Absent phalangeal crease (HP:0006109) | 2.92430787 |
| 47 | Abnormality of macular pigmentation (HP:0008002) | 2.91681761 |
| 48 | Bundle branch block (HP:0011710) | 2.86529715 |
| 49 | Mitochondrial inheritance (HP:0001427) | 2.84184066 |
| 50 | Ketoacidosis (HP:0001993) | 2.82916145 |
| 51 | Hepatic necrosis (HP:0002605) | 2.80215366 |
| 52 | Frequent falls (HP:0002359) | 2.79941533 |
| 53 | Bronchiectasis (HP:0002110) | 2.79397802 |
| 54 | Retinal dysplasia (HP:0007973) | 2.75700342 |
| 55 | Testicular neoplasm (HP:0010788) | 2.75405856 |
| 56 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.73286485 |
| 57 | Hyperglycemia (HP:0003074) | 2.71435873 |
| 58 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.68129930 |
| 59 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.65801007 |
| 60 | Laryngomalacia (HP:0001601) | 2.65102041 |
| 61 | Chronic sinusitis (HP:0011109) | 2.64878244 |
| 62 | Germ cell neoplasia (HP:0100728) | 2.64312825 |
| 63 | Hepatocellular necrosis (HP:0001404) | 2.62138513 |
| 64 | Synostosis involving the elbow (HP:0003938) | 2.61564809 |
| 65 | Humeroradial synostosis (HP:0003041) | 2.61564809 |
| 66 | Increased CSF lactate (HP:0002490) | 2.60656483 |
| 67 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.59978805 |
| 68 | Subaortic stenosis (HP:0001682) | 2.59978805 |
| 69 | Optic nerve hypoplasia (HP:0000609) | 2.59495536 |
| 70 | Absent speech (HP:0001344) | 2.58328625 |
| 71 | Absent septum pellucidum (HP:0001331) | 2.55166092 |
| 72 | Large for gestational age (HP:0001520) | 2.53288026 |
| 73 | Abnormality of the septum pellucidum (HP:0007375) | 2.53245264 |
| 74 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51077292 |
| 75 | Difficulty running (HP:0009046) | 2.50101018 |
| 76 | Male pseudohermaphroditism (HP:0000037) | 2.49920847 |
| 77 | Acute encephalopathy (HP:0006846) | 2.49809186 |
| 78 | Anosmia (HP:0000458) | 2.49786156 |
| 79 | Exercise intolerance (HP:0003546) | 2.42517778 |
| 80 | Areflexia of lower limbs (HP:0002522) | 2.42482414 |
| 81 | Malignant hyperthermia (HP:0002047) | 2.40811688 |
| 82 | Myotonia (HP:0002486) | 2.40641130 |
| 83 | Hypoglycemic coma (HP:0001325) | 2.40538533 |
| 84 | Muscle stiffness (HP:0003552) | 2.40443442 |
| 85 | Abnormal finger flexion creases (HP:0006143) | 2.40386547 |
| 86 | Asymmetric septal hypertrophy (HP:0001670) | 2.40142562 |
| 87 | Breast aplasia (HP:0100783) | 2.40123338 |
| 88 | Hyperglycinemia (HP:0002154) | 2.37546647 |
| 89 | Sudden death (HP:0001699) | 2.35185283 |
| 90 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.34987869 |
| 91 | Pulmonary artery stenosis (HP:0004415) | 2.30098967 |
| 92 | Erectile abnormalities (HP:0100639) | 2.29623523 |
| 93 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 2.29297292 |
| 94 | Delayed CNS myelination (HP:0002188) | 2.23657177 |
| 95 | Intellectual disability, moderate (HP:0002342) | 2.22549463 |
| 96 | Short tibia (HP:0005736) | 2.20371651 |
| 97 | Increased intramyocellular lipid droplets (HP:0012240) | 2.18952085 |
| 98 | Nephronophthisis (HP:0000090) | 2.18600194 |
| 99 | Clitoromegaly (HP:0000057) | 2.18529303 |
| 100 | Median cleft lip (HP:0000161) | 2.17390549 |
| 101 | Fetal akinesia sequence (HP:0001989) | 2.17364674 |
| 102 | Hypothermia (HP:0002045) | 2.17012985 |
| 103 | Generalized muscle weakness (HP:0003324) | 2.16639932 |
| 104 | Optic disc pallor (HP:0000543) | 2.16162521 |
| 105 | Abnormality of the pulmonary veins (HP:0011718) | 2.15802908 |
| 106 | Dysphonia (HP:0001618) | 2.14959894 |
| 107 | Delayed myelination (HP:0012448) | 2.14497995 |
| 108 | Ocular albinism (HP:0001107) | 2.13968273 |
| 109 | Facial diplegia (HP:0001349) | 2.08964618 |
| 110 | Calcaneovalgus deformity (HP:0001848) | 2.07482065 |
| 111 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.07060546 |
| 112 | Lipid accumulation in hepatocytes (HP:0006561) | 2.06456864 |
| 113 | Late onset (HP:0003584) | 2.06161233 |
| 114 | Hyperkalemia (HP:0002153) | 2.05964649 |
| 115 | Abnormal lung lobation (HP:0002101) | 2.04442547 |
| 116 | Methylmalonic acidemia (HP:0002912) | 2.04296047 |
| 117 | Abnormality of the nasal mucosa (HP:0000433) | 2.03879000 |
| 118 | 3-Methylglutaconic aciduria (HP:0003535) | 2.03773858 |
| 119 | Palpitations (HP:0001962) | 2.03691957 |
| 120 | Respiratory failure (HP:0002878) | 2.01355632 |
| 121 | Molar tooth sign on MRI (HP:0002419) | 2.00446815 |
| 122 | Abnormality of midbrain morphology (HP:0002418) | 2.00446815 |
| 123 | Increased hepatocellular lipid droplets (HP:0006565) | 2.00184558 |
| 124 | Lactic acidosis (HP:0003128) | 2.00119507 |
| 125 | Increased muscle lipid content (HP:0009058) | 1.99981526 |
| 126 | Deformed tarsal bones (HP:0008119) | 1.97703288 |
| 127 | Abnormality of the renal cortex (HP:0011035) | 1.95371555 |
| 128 | Weak cry (HP:0001612) | 1.95210851 |
| 129 | EMG: neuropathic changes (HP:0003445) | 1.94150449 |
| 130 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.93537368 |
| 131 | Increased variability in muscle fiber diameter (HP:0003557) | 1.93278989 |
| 132 | Hemiparesis (HP:0001269) | 1.92421016 |
| 133 | Cerebral edema (HP:0002181) | 1.90582230 |
| 134 | Limb dystonia (HP:0002451) | 1.90086828 |
| 135 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.89954638 |
| 136 | Absent/shortened dynein arms (HP:0200106) | 1.89954638 |
| 137 | Anencephaly (HP:0002323) | 1.89851661 |
| 138 | Tongue fasciculations (HP:0001308) | 1.89613795 |
| 139 | Hypoplasia of the radius (HP:0002984) | 1.89189972 |
| 140 | Fatigable weakness (HP:0003473) | 1.86533829 |
| 141 | Abnormality of the neuromuscular junction (HP:0003398) | 1.86533829 |
| 142 | Midline defect of the nose (HP:0004122) | 1.86348244 |
| 143 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.85217662 |
| 144 | Muscular dystrophy (HP:0003560) | 1.85144571 |
| 145 | Nonprogressive disorder (HP:0003680) | 1.84571336 |
| 146 | Dicarboxylic aciduria (HP:0003215) | 1.84309920 |
| 147 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84309920 |
| 148 | Abnormality of vitamin B metabolism (HP:0004340) | 1.84288187 |
| 149 | Progressive muscle weakness (HP:0003323) | 1.84032085 |
| 150 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.83788887 |
| 151 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.83788887 |
| 152 | Heart block (HP:0012722) | 1.82458511 |
| 153 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.81657826 |
| 154 | Conjunctival hamartoma (HP:0100780) | 1.79651926 |
| 155 | Dilated cardiomyopathy (HP:0001644) | 1.79314537 |
| 156 | Nasal polyposis (HP:0100582) | 1.78901082 |
| 157 | Concave nail (HP:0001598) | 1.78408060 |
| 158 | Ventricular arrhythmia (HP:0004308) | 1.78022621 |
| 159 | Muscle fibrillation (HP:0010546) | 1.76670721 |
| 160 | Cleft eyelid (HP:0000625) | 1.76607489 |
| 161 | Bifid tongue (HP:0010297) | 1.75998601 |
| 162 | Pancreatic cysts (HP:0001737) | 1.75638157 |
| 163 | Paralysis (HP:0003470) | 1.75000431 |
| 164 | Iris hypopigmentation (HP:0007730) | 1.74191598 |
| 165 | Malnutrition (HP:0004395) | 1.74162072 |
| 166 | Delayed gross motor development (HP:0002194) | 1.74134451 |
| 167 | Complete atrioventricular canal defect (HP:0001674) | 1.71594215 |
| 168 | Prolonged QT interval (HP:0001657) | 1.68776983 |
| 169 | Renal cortical cysts (HP:0000803) | 1.68653638 |
| 170 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.67946090 |
| 171 | Type 2 muscle fiber atrophy (HP:0003554) | 1.67609043 |
| 172 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.67538792 |
| 173 | Cutaneous finger syndactyly (HP:0010554) | 1.67302346 |
| 174 | Methylmalonic aciduria (HP:0012120) | 1.67033249 |
| 175 | True hermaphroditism (HP:0010459) | 1.66866010 |
| 176 | Atrioventricular canal defect (HP:0006695) | 1.64146142 |
| 177 | Testicular atrophy (HP:0000029) | 1.64128343 |
| 178 | Congenital hepatic fibrosis (HP:0002612) | 1.63883426 |
| 179 | Peripheral hypomyelination (HP:0007182) | 1.62552320 |
| 180 | Prolonged neonatal jaundice (HP:0006579) | 1.61293629 |
| 181 | Intrahepatic cholestasis (HP:0001406) | 1.61074295 |
| 182 | Cerebral palsy (HP:0100021) | 1.60941285 |
| 183 | Generalized hypotonia (HP:0001290) | 1.60142529 |
| 184 | Bronchitis (HP:0012387) | 1.59856412 |
| 185 | Anomalous pulmonary venous return (HP:0010772) | 1.57814587 |
| 186 | Pruritus (HP:0000989) | 1.57625913 |
| 187 | Renal hypoplasia (HP:0000089) | 1.57266447 |
| 188 | Trismus (HP:0000211) | 1.57100071 |
| 189 | Ketosis (HP:0001946) | 1.57039259 |
| 190 | Gait imbalance (HP:0002141) | 1.55643720 |
| 191 | Esotropia (HP:0000565) | 1.55189746 |
| 192 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.54150968 |
| 193 | Abnormality of the renal medulla (HP:0100957) | 1.52504998 |
| 194 | Poikilocytosis (HP:0004447) | 1.51540572 |
| 195 | Congenital primary aphakia (HP:0007707) | 1.51323380 |
| 196 | Intestinal atresia (HP:0011100) | 1.50971068 |
| 197 | Hypoplasia of the ulna (HP:0003022) | 1.50586794 |
| 198 | Abnormality of sodium homeostasis (HP:0010931) | 1.50285655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.98372920 |
| 2 | * PHKG1 | 4.03265330 |
| 3 | PINK1 | 3.64283320 |
| 4 | MKNK2 | 3.44779746 |
| 5 | TTN | 3.02381476 |
| 6 | TLK1 | 2.96203160 |
| 7 | NLK | 2.86350110 |
| 8 | MAPK15 | 2.59546227 |
| 9 | MAP4K2 | 2.02170626 |
| 10 | CASK | 10.8310047 |
| 11 | MAP2K6 | 1.92298451 |
| 12 | MAPKAPK3 | 1.91476339 |
| 13 | PKN1 | 1.90465470 |
| 14 | MKNK1 | 1.79465831 |
| 15 | DYRK3 | 1.77882128 |
| 16 | BMPR1B | 1.70430520 |
| 17 | CDK12 | 1.70068071 |
| 18 | ADRBK2 | 1.68216277 |
| 19 | CSNK1G1 | 1.66211572 |
| 20 | PRKAA2 | 1.65169706 |
| 21 | FGFR2 | 1.61527549 |
| 22 | TRPM7 | 1.54832065 |
| 23 | MAP3K1 | 1.51360058 |
| 24 | PAK1 | 1.47966992 |
| 25 | MUSK | 1.47121430 |
| 26 | NUAK1 | 1.45639287 |
| 27 | PAK2 | 1.45127030 |
| 28 | SRPK1 | 1.42899310 |
| 29 | ICK | 1.38240740 |
| 30 | IKBKE | 1.36981367 |
| 31 | BLK | 1.36152829 |
| 32 | NME1 | 1.32252370 |
| 33 | GRK1 | 1.29092134 |
| 34 | FES | 1.27974828 |
| 35 | DYRK2 | 1.27305203 |
| 36 | WNK3 | 1.25607883 |
| 37 | FER | 1.23066612 |
| 38 | IRAK1 | 1.22574239 |
| 39 | HIPK2 | 1.21524984 |
| 40 | MAPK12 | 1.18843461 |
| 41 | DYRK1A | 1.17499401 |
| 42 | CAMK2B | 1.14145541 |
| 43 | CAMK2G | 1.13126002 |
| 44 | MAP3K2 | 1.12360296 |
| 45 | ILK | 1.12196253 |
| 46 | DAPK3 | 1.09308422 |
| 47 | ERBB3 | 1.09008235 |
| 48 | LIMK1 | 1.08081904 |
| 49 | EIF2AK3 | 1.06308871 |
| 50 | OXSR1 | 1.03897346 |
| 51 | CSNK1A1L | 1.00361130 |
| 52 | ZAK | 0.99221173 |
| 53 | TIE1 | 0.99167672 |
| 54 | CAMK2D | 0.98630257 |
| 55 | CAMK1G | 0.98272481 |
| 56 | ACVR1B | 0.95200348 |
| 57 | IRAK4 | 0.91986957 |
| 58 | TBK1 | 0.91461867 |
| 59 | IRAK2 | 0.89434113 |
| 60 | RPS6KA4 | 0.88413083 |
| 61 | YES1 | 0.88343858 |
| 62 | CLK1 | 0.86107897 |
| 63 | MAPK13 | 0.85691335 |
| 64 | CDK7 | 0.84991435 |
| 65 | STK16 | 0.81649488 |
| 66 | BRD4 | 0.80421443 |
| 67 | MAP2K4 | 0.79099904 |
| 68 | PRKAA1 | 0.77375058 |
| 69 | EPHA2 | 0.77121596 |
| 70 | WNK4 | 0.76045499 |
| 71 | CAMK1D | 0.76025778 |
| 72 | MAP2K3 | 0.75950642 |
| 73 | MAP3K7 | 0.75935095 |
| 74 | CDC7 | 0.75699703 |
| 75 | VRK2 | 0.75564067 |
| 76 | PIK3CG | 0.74958111 |
| 77 | IRAK3 | 0.71163137 |
| 78 | CSNK1G3 | 0.70448885 |
| 79 | ERBB4 | 0.69549048 |
| 80 | PLK2 | 0.69166393 |
| 81 | CDK4 | 0.65318646 |
| 82 | DYRK1B | 0.63884867 |
| 83 | PTK2B | 0.62129328 |
| 84 | PAK3 | 0.62036413 |
| 85 | PRKCE | 0.61883879 |
| 86 | EIF2AK2 | 0.61820603 |
| 87 | IKBKB | 0.60765970 |
| 88 | MAP3K12 | 0.60092050 |
| 89 | MAP3K4 | 0.59106054 |
| 90 | CCNB1 | 0.58775324 |
| 91 | TNK2 | 0.58376130 |
| 92 | MAPK11 | 0.56915781 |
| 93 | FGFR3 | 0.56657691 |
| 94 | PNCK | 0.56191393 |
| 95 | BCKDK | 0.54570283 |
| 96 | GSK3A | 0.53983648 |
| 97 | PIK3CA | 0.53347276 |
| 98 | CSK | 0.53111832 |
| 99 | STK39 | 0.51599174 |
| 100 | CDK3 | 0.51323941 |
| 101 | MAPK10 | 0.51308574 |
| 102 | STK11 | 0.50986328 |
| 103 | TXK | 0.50653063 |
| 104 | NTRK3 | 0.49810012 |
| 105 | CSNK1D | 0.49528808 |
| 106 | ROCK1 | 0.49299408 |
| 107 | TNIK | 0.48727103 |
| 108 | * PRKACA | 0.48073701 |
| 109 | STK38L | 0.47690965 |
| 110 | PBK | 0.47030911 |
| 111 | PRKD1 | 0.47027493 |
| 112 | FGR | 0.45314829 |
| 113 | CSNK1G2 | 0.44719352 |
| 114 | VRK1 | 0.44371147 |
| 115 | MAP3K3 | 0.43959389 |
| 116 | RPS6KA5 | 0.43581921 |
| 117 | UHMK1 | 0.43187116 |
| 118 | CSNK1E | 0.42772483 |
| 119 | EIF2AK1 | 0.41945501 |
| 120 | CDK9 | 0.40899739 |
| 121 | AKT3 | 0.40422585 |
| 122 | ADRBK1 | 0.38997270 |
| 123 | SGK223 | 0.37892514 |
| 124 | SGK494 | 0.37892514 |
| 125 | TGFBR2 | 0.37618777 |
| 126 | PRKCQ | 0.37334310 |
| 127 | STK3 | 0.37070941 |
| 128 | MAP2K1 | 0.37008248 |
| 129 | AURKA | 0.36844872 |
| 130 | MAPKAPK5 | 0.36789205 |
| 131 | CAMK4 | 0.36378274 |
| 132 | DAPK2 | 0.35592158 |
| 133 | * PRKG1 | 0.35400625 |
| 134 | CAMK2A | 0.34521101 |
| 135 | PRKCI | 0.34329453 |
| 136 | MAP2K2 | 0.34249634 |
| 137 | KIT | 0.33085203 |
| 138 | AKT2 | 0.32258112 |
| 139 | SGK1 | 0.31361106 |
| 140 | ERBB2 | 0.31135471 |
| 141 | TAOK3 | 0.31045106 |
| 142 | MST4 | 0.30809271 |
| 143 | OBSCN | 0.30690020 |
| 144 | PDK2 | 0.30576119 |
| 145 | PRKD2 | 0.30510972 |
| 146 | ROCK2 | 0.29902231 |
| 147 | TESK2 | 0.29566481 |
| 148 | PRKCG | 0.28512075 |
| 149 | INSRR | 0.27890245 |
| 150 | SGK2 | 0.27712296 |
| 151 | MARK3 | 0.27488662 |
| 152 | CSNK2A2 | 0.26564620 |
| 153 | STK24 | 0.26137385 |
| 154 | CAMK1 | 0.25501027 |
| 155 | PRKCA | 0.25474839 |
| 156 | NEK1 | 0.25364971 |
| 157 | MYLK | 0.24994603 |
| 158 | PLK3 | 0.22956583 |
| 159 | AURKB | 0.22760063 |
| 160 | MAPK7 | 0.22215817 |
| 161 | PRPF4B | 0.22150303 |
| 162 | CSNK1A1 | 0.20401535 |
| 163 | * PHKG2 | 0.19476711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 8.33054490 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 4.60627534 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.55408476 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.86292581 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 2.82331429 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.76880443 |
| 7 | Circadian rhythm_Homo sapiens_hsa04710 | 2.38773885 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.35100946 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32322262 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.22394973 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.20225883 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.16854345 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.14577174 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.03951892 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00793316 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.99551670 |
| 17 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.96570416 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.95021127 |
| 19 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.94745001 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.85073136 |
| 21 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.81702094 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.71427830 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.71086190 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.69243503 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64936172 |
| 26 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.63100540 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.60166072 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.56566642 |
| 29 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.54421182 |
| 30 | Spliceosome_Homo sapiens_hsa03040 | 1.53409914 |
| 31 | Axon guidance_Homo sapiens_hsa04360 | 1.49613514 |
| 32 | Melanogenesis_Homo sapiens_hsa04916 | 1.45875592 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.45633246 |
| 34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.45271968 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.44411290 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.41804107 |
| 37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.37544635 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.33821900 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.33198515 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.27264578 |
| 41 | Protein export_Homo sapiens_hsa03060 | 1.24761624 |
| 42 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.23908016 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.21082988 |
| 44 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.20552505 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.19636081 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.16715104 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16391253 |
| 48 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.15987614 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.15145507 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.11232645 |
| 51 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10208861 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08254181 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.06584965 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.01322580 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.00717721 |
| 56 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.00188638 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00043029 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.98326785 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.96761494 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.96258963 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.96089247 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93640581 |
| 63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92899356 |
| 64 | RNA polymerase_Homo sapiens_hsa03020 | 0.91483847 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.88990242 |
| 66 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.88823585 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87099828 |
| 68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86543590 |
| 69 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85734344 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85644275 |
| 71 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.79951413 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.79434581 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.77058188 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.76748261 |
| 75 | Long-term depression_Homo sapiens_hsa04730 | 0.76148585 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75482446 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75082979 |
| 78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74907814 |
| 79 | Circadian entrainment_Homo sapiens_hsa04713 | 0.74708426 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74293902 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73852853 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73253182 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73173669 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72625563 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72320537 |
| 86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72088409 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.71989020 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.71939684 |
| 89 | RNA degradation_Homo sapiens_hsa03018 | 0.71636659 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71635067 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71399517 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70440217 |
| 93 | Carbon metabolism_Homo sapiens_hsa01200 | 0.70321365 |
| 94 | Alcoholism_Homo sapiens_hsa05034 | 0.68166009 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | 0.67846991 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66526330 |
| 97 | Ribosome_Homo sapiens_hsa03010 | 0.66318298 |
| 98 | Basal transcription factors_Homo sapiens_hsa03022 | 0.66263359 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.65671257 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.65243780 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63865835 |
| 102 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61975870 |
| 103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.61703678 |
| 104 | Morphine addiction_Homo sapiens_hsa05032 | 0.60913999 |
| 105 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58522337 |
| 106 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.56814344 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56466723 |
| 108 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55268932 |
| 109 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.54190366 |
| 110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54110080 |
| 111 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.49853683 |
| 112 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.49814000 |
| 113 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49798072 |
| 114 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49638641 |
| 115 | Proteasome_Homo sapiens_hsa03050 | 0.49056594 |
| 116 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48948064 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.48323439 |
| 118 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.46450568 |
| 119 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46003353 |
| 120 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.45448209 |
| 121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44777743 |
| 122 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43922870 |
| 123 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40283014 |
| 124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40122174 |
| 125 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38705080 |
| 126 | DNA replication_Homo sapiens_hsa03030 | 0.38057983 |
| 127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37697285 |
| 128 | Melanoma_Homo sapiens_hsa05218 | 0.37619187 |
| 129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.36803453 |
| 130 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.35507873 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35335308 |
| 132 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.34556147 |
| 133 | Hepatitis B_Homo sapiens_hsa05161 | 0.34369591 |
| 134 | Huntingtons disease_Homo sapiens_hsa05016 | 0.34302251 |
| 135 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.34248213 |
| 136 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.32521523 |
| 137 | Insulin secretion_Homo sapiens_hsa04911 | 0.31864611 |
| 138 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31497525 |
| 139 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.31489766 |
| 140 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31009493 |
| 141 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30821280 |
| 142 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.30608212 |
| 143 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30151658 |
| 144 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28936558 |
| 145 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.28447200 |
| 146 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.27817901 |
| 147 | GABAergic synapse_Homo sapiens_hsa04727 | 0.26605916 |
| 148 | Salivary secretion_Homo sapiens_hsa04970 | 0.26175311 |
| 149 | Renin secretion_Homo sapiens_hsa04924 | 0.26150158 |
| 150 | Prion diseases_Homo sapiens_hsa05020 | 0.26038098 |
| 151 | Gap junction_Homo sapiens_hsa04540 | 0.25302466 |
| 152 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24469593 |
| 153 | Homologous recombination_Homo sapiens_hsa03440 | 0.24441697 |
| 154 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.21842496 |
| 155 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.21519719 |
| 156 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18717051 |

